Form D · Biotechnology
Color Health, Inc.
Burlingame, CA · CIK 0001683327
Offering snapshot reported Nov 9, 2021 · SEC filing
- Reported sold
- $45.7M Offering amount: $100M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 26, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 9, 2021 | Initial | $45,690,932 | No comparison | 18 | SEC filing |
| Jan 4, 2021 | Initial | $127,224,203 | No comparison | 13 | SEC filing |
| Nov 14, 2017 | Amendment | $89,444,402 | $37,454,540vs Aug 16, 2017 | 51 | SEC filing |
| Aug 16, 2017 | Initial | $51,989,862 | No comparison | 29 | SEC filing |
| Aug 29, 2016 | Initial | $38,548,112 | No comparison | 38 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-420373
Source: Form D, filed Nov 9, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sherwin Chen | Executive |
| Gil Elad | Director |
| Elad Gil | Director |
| Taneja Hemant | Director |
| Michael Herring | Executive |
| Othman Laraki | Director, Executive |
| Hemant Taneja | Director |
| Susan L. Wagner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
831 Mitten Road, Suite #100
Burlingame, CA, 94010
Burlingame, CA, 94010